Linzess (Linaclotide) for Chronic Constipation

Introduction to Linzess

The American Gastroenterological Association recommends Linzess as a highly effective second-line treatment for chronic constipation in adults who fail over-the-counter laxatives, with strong guideline support and high-quality evidence demonstrating significant improvements in bowel movements, stool consistency, and quality of life 1, 2

The British Society of Gastroenterology considers linaclotide the most efficacious secretagogue available for constipation, with strong recommendation and high-quality evidence 6
Start with over-the-counter laxatives first as initial therapy for chronic idiopathic constipation (CIC) 1
Add or switch to Linzess when OTC agents provide inadequate relief after an appropriate trial period 1, 2
Linzess can be used either as a replacement for OTC agents or as an adjunct to them, providing flexibility in treatment approach 2, 3
Particularly beneficial for patients with concurrent abdominal symptoms including bloating, discomfort, or pain, as linaclotide addresses these symptoms through its dual mechanism 2, 4

Linzess increases complete spontaneous bowel movements (CSBMs) by 1.37 per week compared to placebo 2, 5
Linzess increases spontaneous bowel movements (SBMs) by 1.97 per week compared to placebo 2, 5
Linzess improves stool consistency significantly (mean difference 1.25 on Bristol Stool Scale) 2, 5
Linzess triples responder rates compared to placebo (RR 3.14) 2, 5
Linzess doubles global symptom relief rates (RR 1.96) 2, 5

Diarrhea occurs in approximately 16% of patients on linaclotide versus 2-3% on placebo 4
Discontinuation due to diarrhea occurs in approximately 3-5% of patients 2, 4
No serious adverse events due to diarrhea were reported in clinical trials 4

Efficacy appears similar in patients over 65 years compared to younger adults, though sample sizes in studies were limited 2, 5
Use with caution in patients on diuretics or other medications affecting sodium balance due to potential hyponatremia risk 5

Linzess can be safely combined with polyethylene glycol (PEG)-based laxatives like Miralax or Movicol for patients with inadequate response to either agent alone 3, 7
Start with PEG-based laxative first as initial OTC therapy, and add Linzess only after adequate trial of OTC agent provides insufficient relief 3, 7
Do not start both agents simultaneously in treatment-naive patients to avoid excessive bowel response 7